DALLAS — A U.S. judge on Thursday rejected a bid by compounding pharmacies to keep making copies of Novo Nordisk's popular diabetes and weight-loss drugs Ozempic and Wegovy while a legal challenge ...
Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Novo Nordisk has asked ...
A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli Lilly’s weight loss and diabetes drugs Zepbound and Mounjaro. In a sealed decision filed ...
March 10 (Reuters) - The U.S. Food and Drug Administration said on Monday it will not take action against compounding pharmacies making copies of Novo Nordisk's (NOVOb.CO), opens new tab weight-loss ...
Locked out? Lost your spare? Key not working right? Don’t call a locksmith — fix it yourself! Spare keys are great because they can come in handy in an emergency. Preparation is key, so don’t wait ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results